A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAX (R) in Healthy Adults in Taiwan
Phase of Trial: Phase III
Latest Information Update: 11 Feb 2015
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 20 Oct 2008 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 20 Oct 2008 Actual study start date changed from (Mar 2007) to (Feb 2007) reported by ClinicalTrials.gov.
- 20 Oct 2008 Trial identifier changed from (V211-019) to (MKV211-019) as reported by ClinicalTrials.gov.